Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of Ovarian Reserve in Women With Rheumatologic Diseases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02273869
Recruitment Status : Unknown
Verified September 2014 by Meir Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : October 24, 2014
Last Update Posted : October 24, 2014
Sponsor:
Information provided by (Responsible Party):
Meir Medical Center

Brief Summary:
Our infertility unit has started a clinic for women with rheumatological diseases. those women are prone to infertility problems and it might be due to their illness or cytotoxic treatment . In our study we are going to observe the effect of their disease on ovarian reserve. we will assess it by using intravaginal sonography and blood test such as hormonal profile and anti-mullerian hormone (AMH).

Condition or disease
Rheumatologic Diseases Ovarian Reserve Infertility

Layout table for study information
Study Type : Observational
Estimated Enrollment : 300 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Influence of Rheumatologic Diseases on Fertility and Ovarian Reserve
Study Start Date : December 2014
Estimated Primary Completion Date : April 2018
Estimated Study Completion Date : April 2018



Primary Outcome Measures :
  1. hormone profile [ Time Frame: 4 years ]
    Assessment of ovarian function using hormone profile and AMH levels in serum, in women with rheumatologic disease.

  2. antral follicular count [ Time Frame: 4 years ]
    we will use sonography to assess the antral follicular count as a parameter for ovarian reserve in women with rheumatologic disease.


Biospecimen Retention:   Samples Without DNA
serum blood test


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   12 Years to 45 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women in reproductive age with rheumatoligic disease
Criteria

Inclusion Criteria:

  • Rheumatologic disease

Exclusion Criteria:

  • none

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02273869


Contacts
Layout table for location contacts
Contact: Einat Haikin HErzberger, M.D 972-506728987 einatcha1@yahoo.com

Locations
Layout table for location information
Israel
Sapir Medical Center, Meir Hospital
Kfar-Saba, Israel
Sponsors and Collaborators
Meir Medical Center

Layout table for additonal information
Responsible Party: Meir Medical Center
ClinicalTrials.gov Identifier: NCT02273869    
Other Study ID Numbers: MMC-011413-CTIL
First Posted: October 24, 2014    Key Record Dates
Last Update Posted: October 24, 2014
Last Verified: September 2014
Additional relevant MeSH terms:
Layout table for MeSH terms
Infertility
Genital Diseases, Male
Genital Diseases, Female